Peter Santer

3.6k total citations · 1 hit paper
26 papers, 2.5k citations indexed

About

Peter Santer is a scholar working on Cancer Research, Molecular Biology and Surgery. According to data from OpenAlex, Peter Santer has authored 26 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 7 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Peter Santer's work include Lipoproteins and Cardiovascular Health (6 papers), Cancer, Lipids, and Metabolism (4 papers) and MicroRNA in disease regulation (4 papers). Peter Santer is often cited by papers focused on Lipoproteins and Cardiovascular Health (6 papers), Cancer, Lipids, and Metabolism (4 papers) and MicroRNA in disease regulation (4 papers). Peter Santer collaborates with scholars based in Austria, Italy and United Kingdom. Peter Santer's co-authors include Johann Willeit, Stefan Kiechl, Manuel Mayr, Peter Willeit, Agnes Mayr, Georg Egger, Sotirios Tsimikas, Georg Schett, Florian Kronenberg and Qingbo Xu and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Diabetes.

In The Last Decade

Peter Santer

25 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lipidomics Profiling and Risk of Cardiovascular Disease in the Prospective Population-Based Bruneck Study

2014 418 citations Christin Stegemann, Raimund Pechlaner et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Santer Austria	18	1.0k	789	573	477	387	26	2.5k
Bernd Hohenstein Germany	26	1.1k 1.1×	722 0.9×	445 0.8×	362 0.8×	650 1.7×	87	3.1k
Elda Favari Italy	30	664 0.7×	1.4k 1.8×	543 0.9×	449 0.9×	341 0.9×	73	2.5k
Miguel Ángel Hernández-Presa Spain	16	581 0.6×	802 1.0×	387 0.7×	713 1.5×	657 1.7×	26	2.4k
Mónica Ortego Spain	14	639 0.6×	939 1.2×	427 0.7×	616 1.3×	618 1.6×	20	2.3k
Marina Camera Italy	33	717 0.7×	1.1k 1.4×	459 0.8×	1.1k 2.3×	695 1.8×	108	3.9k
Julia Blanco Spain	28	854 0.8×	292 0.4×	334 0.6×	537 1.1×	521 1.3×	43	2.7k
Rui‐Xia Xu China	33	785 0.8×	1.7k 2.2×	630 1.1×	1.0k 2.1×	418 1.1×	158	3.5k
Jürgen Meyer Germany	20	578 0.6×	697 0.9×	424 0.7×	747 1.6×	539 1.4×	32	2.6k
Livia Pisciotta Italy	26	497 0.5×	1.4k 1.7×	431 0.8×	566 1.2×	143 0.4×	105	2.3k
Thimoteus Speer Germany	27	640 0.6×	534 0.7×	217 0.4×	497 1.0×	239 0.6×	80	2.5k

Countries citing papers authored by Peter Santer

Since Specialization

Citations

This map shows the geographic impact of Peter Santer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Santer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Santer more than expected).

Fields of papers citing papers by Peter Santer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Santer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Santer. The network helps show where Peter Santer may publish in the future.

Co-authorship network of co-authors of Peter Santer

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Santer. A scholar is included among the top collaborators of Peter Santer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Santer. Peter Santer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gutmann, Clemens, Temo Barwari, Christian Schulte, et al.. (2025). Platelets and inflammation—insights from platelet non-coding RNA content and release in the Bruneck study and the PACMAN-AMI trial. Cardiovascular Research. 121(9). 1392–1406.

Si, Jiyeon, Jorge F. Vázquez‐Castellanos, Ann Gregory, et al.. (2022). Long-term life history predicts current gut microbiome in a population-based cohort study. Nature Aging. 2(10). 885–895. 18 indexed citations

Willeit, Karin, Peter Santer, Lena Tschiderer, et al.. (2022). Association of desphospho-uncarboxylated matrix gla protein with incident cardiovascular disease and all-cause mortality: Results from the prospective Bruneck Study. Atherosclerosis. 353. 20–27. 4 indexed citations

Barwari, Temo, Seda Eminaga, Paul C. Armstrong, et al.. (2017). Abstract 19935: MicroRNA-21 Regulates Transforming Growth Factor Beta-1 Release From Platelets: A Novel Mechanism for the Anti-Fibrotic Effects of MicroRNA-21 Inhibition. Circulation. 1 indexed citations

Paige, Ellie, Katya L Masconi, Sotirios Tsimikas, et al.. (2017). Lipoprotein(a) and incident type-2 diabetes: results from the prospective Bruneck study and a meta-analysis of published literature. Cardiovascular Diabetology. 16(1). 38–38. 80 indexed citations

Pechlaner, Raimund, Sotirios Tsimikas, Xiaoke Yin, et al.. (2017). Very-Low-Density Lipoprotein–Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III. Journal of the American College of Cardiology. 69(7). 789–800. 130 indexed citations

Yin, Xiaoke, Ferheen Baig, Richard T. Blankley, et al.. (2017). Plasma Proteomics for Epidemiology. Circulation Cardiovascular Genetics. 10(6). 12 indexed citations

Willeit, Peter, Philipp Skroblin, Alexander R. Moschen, et al.. (2016). Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes. Diabetes. 66(2). 347–357. 201 indexed citations

Pechlaner, Raimund, Stefan Kiechl, Manuel Mayr, et al.. (2015). Correlates of serum hepcidin levels and its association with cardiovascular disease in an elderly general population. Clinical Chemistry and Laboratory Medicine (CCLM). 54(1). 151–61. 21 indexed citations

10.

Willeit, Peter, Stefan Kiechl, Florian Kronenberg, et al.. (2014). Discrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a). Journal of the American College of Cardiology. 64(9). 851–860. 210 indexed citations

11.

Beyer, Christian, Anna Zampetaki, Neng‐Yu Lin, et al.. (2014). Signature of circulating microRNAs in osteoarthritis. Annals of the Rheumatic Diseases. 74(3). e18–e18. 138 indexed citations

12.

Stegemann, Christin, Raimund Pechlaner, Peter Willeit, et al.. (2014). Lipidomics Profiling and Risk of Cardiovascular Disease in the Prospective Population-Based Bruneck Study. Circulation. 129(18). 1821–1831. 418 indexed citations breakdown →

13.

Beyer, Christian, Anna Zampetaki, Arnd Kleyer, et al.. (2014). OP0003 Signature of Circulating Micrornas in Osteoarthritis. Annals of the Rheumatic Diseases. 73. 60–61. 8 indexed citations

14.

Tsimikas, Sotirios, Peter Willeit, Johann Willeit, et al.. (2012). Oxidation-Specific Biomarkers, Prospective 15-Year Cardiovascular and Stroke Outcomes, and Net Reclassification of Cardiovascular Events. Journal of the American College of Cardiology. 60(21). 2218–2229. 168 indexed citations

15.

Kiechl, Stefan, Terry Lee, Peter Santer, et al.. (2008). Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population. Atherosclerosis. 205(1). 261–265. 61 indexed citations

16.

Mayr, Andreas, et al.. (2006). Comparison of Hematologic Data in World Elite Junior Speed Skaters and in Non-Athletic Juniors. International Journal of Sports Medicine. 27(4). 283–288. 15 indexed citations

17.

Kiechl, Stefan, Georg Schett, Gregor K. Wenning, et al.. (2004). Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease. Circulation. 109(18). 2175–2180. 426 indexed citations

18.

Willeit, Johann, Stefan Kiechl, Thomas Weimer, et al.. (2003). Marburg I Polymorphism of Factor VII–Activating Protease. Circulation. 107(5). 667–670. 85 indexed citations

19.

Kronenberg, Florian, Martina F. Kronenberg, Stefan Kiechl, et al.. (1999). Role of Lipoprotein(a) and Apolipoprotein(a) Phenotype in Atherogenesis. Circulation. 100(11). 1154–1160. 225 indexed citations

20.

Kiechl, Stefan, Armin Muigg, Peter Santer, et al.. (1999). Poor Response to Activated Protein C as a Prominent Risk Predictor of Advanced Atherosclerosis and Arterial Disease. Circulation. 99(5). 614–619. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact